Your future with HAL Allergy
HAL Allergy is a mid-sized Pharmaceutical company specialized in therapies and diagnostics for allergic diseases. Our headquarters is located in the Bio Science Park in Leiden, the Netherlands.
With offices in major European countries, HAL Allergy is one of the European top players in the allergy immunotherapy business. Established in 1959 HAL Allergy has a long experience in the development, production and sales of allergy therapies with an immuno-modulatory effect, resulting in a reduction of symptoms and long-term disease suppression. These therapies are primarily used against common allergies such as allergic rhinitis (hay fever), allergic asthma, house dust mites allergy and allergic reactions towards wasp or bee stings.
We employ around 300 highly specialized people across various functions. The departments at our headquarters include Research & Development, Production, Quality Assurance, Clinical Development and Regulatory Affairs. Our staff works closely together with leading research institutes. At our locations in Germany, Poland, Austria, Spain and Italy we mainly focus on service and sales activities.